As the autumn vaccination programme is now underway, regulators have approved another drug designed to fight the Omicron variant of covid.
Swissmedic says the new Pfizer jab can be rolled out across the country.
Like the Moderna vaccine currently in use – the new drug will target the BA.1 Omicron variant – although later mutations are now circulating.
But Pfizer does have another product which is awaiting approval which the makers claim will be effective against the BA.4 and BA.5 variants.
Parliament rejects WHO alcohol policy
Cyclist dies near the UN
Govt may buy fewer F-35s due to cost
Amnesty slams Bern police
Two men given house arrest after stealing vignettes
What's likely under the tree this year?
